Iovance Biotherapeutics has hired Corleen Roche as the biotechnology company's new chief financial officer, effective Aug. 6. Iovance on Tuesday said Roche, 59 years old, most recently served as ...

AI device startup IyO Inc. asked a federal judge to hold Open AI Inc. in civil contempt for “brazenly” violating a temporary ...

The new lawsuit says io co-founder Tang Tan admitted that he received confidential information, including CAD drawings of Iyo’s ear-worn computer, from the startup’s former design and manufacturing ...

The biotechnology sector is hailing a major milestone as Isomorphic Labs, a startup incubated by Google DeepMind, prepares to enter human trials with a drug candidate designed using artificial ...

IO Biotech files for the sale of up to 5.6M shares of common stock for holders May 23, 2025 4:17 PM ET IO Biotech, Inc. (IOBT) Stock By: Nivedita Hazra, SA News Editor Play (<1min) ...

IO Biotech Presents New Data at AACR 2025 Supporting Dual Mechanism and Immune Activation of Cancer Vaccines IO102-IO103 and IO170 ...

NEW YORK, March 18, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company, has been named to Fast Company’s prestigious list of the World’s Most ...

IO Biotech is sponsoring the Phase 2 trial and Merck is supplying pembrolizumab. About IO Biotech IO Biotech is a clinical-stage biopharmaceutical company developing novel, immune-modulatory, ...

The full IO Biotech team is proud to be leading the next frontier of immune-oncology with the development of therapeutic cancer vaccines for these and other difficult-to-treat cancers.